Similar articles

• Immunogenicity of bovine, porcine and semisynthetic human insulin.

  Venekamp WJ, van der Hooft JC, Jacobsen L, van Schaik CL. Venekamp WJ, et al. Neth J Med. 1985;28 Suppl 1:57-8. Neth J Med. 1985. PMID: 3892343 No abstract available.
• [Measurement and clinical significance of insulin antibody and anti-insulin receptor antibody].

  Kobayashi M, Ishibashi O. Kobayashi M, et al. Rinsho Byori. 1985 May;33(5):513-8. Rinsho Byori. 1985. PMID: 4057637 Japanese. No abstract available.
• Insulin antibodies: reduction in various anti-insulin IgG subclasses with human insulin therapy.

  Kumar D. Kumar D. Horm Metab Res. 1993 Jul;25(7):360-4. doi: 10.1055/s-2007-1002120. Horm Metab Res. 1993. PMID: 8406321
• Receptors, antireceptor antibodies and mechanisms of insulin resistance.

  Flier JS, Kahn CR, Roth J. Flier JS, et al. N Engl J Med. 1979 Feb 22;300(8):413-9. doi: 10.1056/NEJM197902223000808. N Engl J Med. 1979. PMID: 366414 Review. No abstract available.
• The immunogenicity of insulin preparations.

  Chance RE, Root MA, Galloway JA. Chance RE, et al. Acta Endocrinol Suppl (Copenh). 1976;205:185-98. Acta Endocrinol Suppl (Copenh). 1976. PMID: 793278 Review.